Delivery Order SPE2DB22D2007-SPE2DB25FJ5DA
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Potassium Citrate ER 10 MEQ tablets. The $1,566.27 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency awarded a $511,730 delivery order to Amerisourcebergen Drug Corporation for potassium citrate extended release tablets. The order is for 100 units of the 10 mEq tablets to support the Department of Defense's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period from September 15 to 18, 2023. The contract utilizes firm fixed pricing and does not appear to have any set-aside designations....
- The Defense Logistics Agency awarded a $28,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for potassium citrate extended release tablets. The order is for 100 units of the 10 mEq product to be delivered to a location in Conshohocken, Pennsylvania by August 7, 2023. Amerisourcebergen Drug Corporation will perform as the prime contractor, with its parent company listed as Amerisourcebergen Corporation. No subcontractors or set aside designations were indicated. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Potassium Chloride ER 20 MEQ tablets (100-count packages) with a ceiling value of $13,579.18. This contract, awarded on September 18, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $398 to Amerisourcebergen Drug Corporation to supply 100 units of 15 mEq potassium citrate extended release tablets. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by June 23, 2023 in support of the DLA's medical supply chain responsibilities. Amerisourcebergen Corporation is the identified parent company for this order...
- The Defense Logistics Agency awarded a $71,260 delivery order to Amerisourcebergen Drug Corporation for potassium citrate extended release tablets. The firm fixed price order is for 100 bottles of 15 milliequivalent potassium citrate tablets to support DLA's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 13 to July 14, 2023. No set aside designation or subcontractors were identified. This order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This contract, valued at $22,252.80 with firm fixed pricing, is scheduled for completion by September 19, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 100 with a ceiling value of $1,167.36. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at three hundred eighty-nine dollars and seventy-four cents to Amerisourcebergen Drug Corporation for potassium citrate extended release tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver one hundred units of the ten milliequivalent potassium citrate tablets to a location in Conshohocken, Pennsylvania by August 29, 2023 to fulfill requirements under the agency's pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,391.20 to AmerisourceBergen Drug Corp for Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This contract award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5DADelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,375.66 by the Defense Logistics Agency (DLA) for Potassium Citrate ER 10 MEQ tablets (100-count bottles). The contract was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. The product will be performed at the company's Conshohocken facility. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This indefinite delivery contract framework allows the Defense Logistics Agency to issue individual delivery orders such as this one for specific pharmaceutical needs, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The competitively awarded status and firm fixed-price structure demonstrate AmerisourceBergen's capability to meet federal procurement requirements for pharmaceutical products and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/18/25 |